Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

By Kamat Siddhesh A.   Bullano Michael F.   Chang Chun-Lan   Gandhi Sanjay K.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 961-968

Informa Healthcare

Access to resources Recommend Favorite

Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement

By Chang Joanne   Yang Weiyi   Fellers Thomas   Kahler Kristijan H.   Orloff John   Xie Jipan   Tsaneva Magda   Yu Andrew P.   Wu Eric Q.  

Current Medical Research and Opinion, Vol. 26, Iss. 9, 2010-09 ,pp. : 2203-2212

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy

By Ke YuanNan   Zhu DingLiang   Hong HuaShan   Zhu JunRen   Wang RuoNan   Cardenas Pamela   Zhang Ying  

Current Medical Research and Opinion, Vol. 26, Iss. 7, 2010-07 ,pp. : 1705-1713

Informa Healthcare

Access to resources Recommend Favorite

Telmisartan plus amlodipine single-pill combination for the management of hypertensive patients with a metabolic risk profile (added-risk patients)

By Ley Ludwin   Schumacher Helmut  

Current Medical Research and Opinion, Vol. 29, Iss. 1, 2013-01 ,pp. : 41-53

Informa Healthcare

Access to resources Recommend Favorite

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence

By Balu Sanjeev   Simko Robert J.   Quimbo Ralph M.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2765-2775

Informa Healthcare

Access to resources Recommend Favorite